Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Avalo Therapeutics, Inc.

NASDAQ: AVTX · Life Sciences · 4 alerts · CIK 1534120

Share price
$7.37Close, Nov 16
Market cap
$426M
Shares outstanding
57.82MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Avalo Therapeutics, Inc. filings on SEC EDGAR ↗

4:11 PM ET Form 4
Insider Selling

Avalo Therapeutics CFO Christopher Ryan Sullivan Sells $202K of Stock

Christopher Ryan Sullivan, CFO, sold 12,394 shares of Avalo Therapeutics, Inc. at $16.33 a share, worth $202K in total on Sep 16, 2026. Shares held after the trade: 39,900 (-23.7%).

Value
$202K
Shares
12,394
Price
$16.33
Role
CFO
Holding change
-23.7%
Trade date
Sep 16, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.